Matrix metalloproteinase-9 is a prognostic marker to predict survival of patients who underwent surgery due to rectal carcinoma.

The Tohoku journal of experimental medicine

Volumn 223, Issue 1, 2011, Pages 67-73

  Svagzdys, Saulius ^a   Lesauskaite, Vaiva ^b   Pangonyte, Dalia ^b   Saladzinskas, Zilvinas ^b   Tamelis, Algimantas ^b   Pavalkis, Dainius ^b  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; MMP2 PROTEIN, HUMAN; TIMP3 PROTEIN, HUMAN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR MARKER;

AGED; ARTICLE; ENZYMOLOGY; FEMALE; HUMAN; KAPLAN MEIER METHOD; MALE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; RECTUM TUMOR;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RECTAL NEOPLASMS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TUMOR MARKERS, BIOLOGICAL;

EID: 79953141512     PISSN: None     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.223.67     Document Type: Article

References (0)